What's Good for the Heart Is Good for the Brain

Dr Edward Leatham
1 day ago
7 min read

The four pillars don't only protect coronary arteries — they map onto reduced dementia risk and better cognitive ageing

For most of the twentieth century, cardiology and neurology occupied separate intellectual territories. Heart disease was a disease of vessels and lipids. Dementia was a disease of plaques and tangles. The conversation about heart and brain happened, when it happened at all, in the context of catastrophic stroke — a downstream complication that linked the two specialties belatedly and almost by accident.

That separation no longer holds. The accumulated evidence of the past twenty years has made it increasingly clear that **the same biological processes that drive coronary atherosclerosis also drive most age-related cognitive decline** [1,2]. Vascular dementia, mixed dementia, and even significant components of Alzheimer's disease share root causes with cardiovascular disease: endothelial dysfunction, chronic low-grade inflammation, insulin resistance, oxidative stress, and reduced cerebral perfusion.

This is not a marginal observation. It is one of the most important shifts in preventive medicine in a generation. And it means that the four-pillar framework — built originally for the coronary patient — turns out to be substantially the same framework for protecting the brain.

---

## The vascular contribution to dementia

When pathologists look at the brains of older adults who have died with dementia, what they typically find is *mixed* pathology. Pure Alzheimer's disease — amyloid plaques and tau tangles with no vascular contribution — is rarer than the textbook diagrams suggest. Pure vascular dementia — multiple small infarcts without amyloid — is also relatively uncommon. The most common picture is a mixed one: amyloid pathology *plus* small-vessel disease, white matter hyperintensities, microinfarcts, and reduced cerebral blood flow [1,3].

The clinical implication is large. If the vascular contribution to cognitive decline is substantial — and the evidence says it is — then the modifiable risk factors for vascular disease are *also* the modifiable risk factors for late-life cognitive decline. The patient who protects their coronary arteries is, by the same set of behaviours, protecting their cerebral arteries.

This is why landmark reports on dementia prevention now identify roughly a dozen modifiable risk factors — including hypertension, diabetes, physical inactivity, obesity, smoking, and excessive alcohol — most of which are also on every cardiovascular prevention checklist [4]. The overlap is not coincidence. It is biology.

---

## Insulin resistance and the brain

A particularly important point of contact between cardiometabolic and cognitive health is **insulin resistance**. The same insulin signalling that goes wrong in the periphery in type 2 diabetes also goes wrong in the brain — to the point that some researchers refer to Alzheimer's disease as "type 3 diabetes" [5].

The brain is profoundly insulin-sensitive. Neurons and glial cells use insulin signalling for glucose uptake, synaptic plasticity, neuroprotection, and the clearance of amyloid-beta peptides. When insulin signalling is impaired — whether in the body or specifically in the brain — neurons lose access to their preferred fuel substrate, the clearance of toxic proteins slows, and the substrate for neurodegeneration accumulates over decades [5,6].

Patients with type 2 diabetes have approximately double the risk of developing dementia compared with metabolically healthy peers, and the risk rises further with longer diabetes duration and worse glycaemic control [6,7]. The relationship is dose-dependent. It also operates upstream of clinical diabetes: people with insulin resistance who have not yet crossed the diagnostic threshold for type 2 diabetes are already accumulating measurable changes in brain structure and function.

The four-pillar framework — which is fundamentally a framework for restoring insulin sensitivity — therefore has direct cognitive implications. Reducing visceral fat, restoring glucose dynamics, building skeletal muscle, and quieting systemic inflammation collectively reduce the biology of brain ageing as much as they reduce the biology of coronary ageing.

---

## Muscle and the mind

The third pillar — skeletal muscle — turns out to be unexpectedly central to brain health.

Skeletal muscle is not merely a glucose disposal site. It is a major endocrine organ secreting a family of myokines, including **BDNF (brain-derived neurotrophic factor)** and irisin, both of which cross the blood-brain barrier and have direct neuroprotective and neurogenic effects [8]. Working muscle, in other words, talks to the hippocampus. Sarcopenic, inactive muscle does not.

This is the biological basis for one of the most robust findings in cognitive epidemiology: regular physical exercise — particularly the combination of aerobic and resistance training — is the single most reproducible modifiable intervention for reducing dementia risk and slowing cognitive decline. Erickson's landmark 2011 trial showed that even a year of moderate aerobic exercise in older adults *increased* hippocampal volume, reversing the slow shrinkage normally associated with ageing [9]. More recent work confirms similar findings for resistance training and combined modalities.

The patient who builds and preserves muscle is not just lowering their insulin demand and their cardiovascular risk. They are sending continuous neurotrophic signals from working muscle to brain tissue that would otherwise be receiving no such signals.

---

## Sleep, blood pressure, and the brain's drainage system

Two more components of the cardiometabolic framework deserve attention in the cognitive context.

**Sleep.** The brain's glymphatic system — the recently characterised network that clears metabolic waste, including amyloid-beta, from brain tissue — operates predominantly during deep sleep [10]. Chronic sleep deprivation, sleep apnoea, and fragmented sleep all impair this clearance and are independent risk factors for both cardiovascular and cognitive disease. Sleeping well is not optional. It is one of the few interventions that touches both cardiovascular and brain biology directly.

**Blood pressure.** Long-term hypertension produces the small-vessel cerebrovascular disease — lacunar infarcts, white matter hyperintensities — that contributes substantially to vascular cognitive impairment. Aggressive blood pressure control in midlife is one of the few interventions with randomised-trial evidence for reducing dementia incidence (notably the SPRINT-MIND trial) [4,11].

Both of these slot directly into the cardiometabolic framework. The patient who keeps blood pressure in range and sleeps consistently for seven to eight hours is making cognitive ageing decisions, not just cardiovascular ones.

---

## Healthspan, not just lifespan

The conventional framing of preventive cardiology — "live longer" — is incomplete. Many older adults today live longer than their parents did, but their additional years are spent in declining physical function and progressive cognitive impairment. The lifespan gain has outpaced the healthspan gain.

The four-pillar framework is, fundamentally, a healthspan framework. Each pillar — vascular health, glycaemic control, muscle mass, inflammation — maps onto both cardiovascular and cognitive endpoints. The patient who runs the framework well is buying not just years but functional years: the ability to think clearly, move independently, recognise faces, hold conversations, manage their own affairs.

The arithmetic of compound interest applies here as strongly as it does in finance. Small biological tilts, sustained over decades, produce large divergences in outcome between people who looked similar at age 50. The patient at 50 who is on top of all four pillars is on a different cognitive trajectory than the patient who is on top of one or two. The difference rarely shows in any single year. It shows at 80.

---

## What this means in practice

For most patients, no new actions are required beyond those already implied by the four-pillar framework:

- **Reduce sugar and refined carbohydrate.** Improves insulin sensitivity in the body and in the brain.

- **Reduce visceral fat.** Reduces the inflammatory substrate that ages both arteries and brain tissue.

- **Build and preserve muscle.** Each session of resistance training sends neurotrophic signals to the brain.

- **Aerobic exercise regularly.** Improves cerebral perfusion, hippocampal volume, and mood.

- **Sleep seven to eight hours, consistently.** Allows glymphatic clearance and metabolic restoration.

- **Control blood pressure.** Protects small cerebral vessels from the slow damage that produces vascular dementia.

- **Stay socially and cognitively engaged.** Independent risk factor; the brain, like muscle, atrophies under disuse.

These are the same decisions the framework prescribes for the heart. The brain just happens to benefit from them too.

---

## The Bottom Line

The four-pillar framework is not a cardiology framework that happens to also help the brain. It is a healthspan framework that addresses the shared root causes of the diseases of late life — cardiovascular, cerebrovascular, metabolic, and cognitive.

The biology is now clear enough that the separation of cardiology from neurology in preventive practice no longer makes sense. The same patient with rising visceral fat, rising fasting insulin, declining muscle, and accumulating inflammation is on a single trajectory that will eventually express itself in arteries, in cognition, or in both — and the modifications that change the trajectory are the same in either case.

What is good for the heart is good for the brain. Lifespan was the twentieth-century goal. Healthspan is the twenty-first. The four pillars are how you measure the difference.

---

**Read deeper:** [The four-pillar framework →](./vat-trap-chapter-1-cgm-double-edged-sword.md) · [The muscle-metabolism loop →](./vat-trap-panel-4-muscle-metabolism-loop.md) · [Book I — Sugars, Belly Fat & Heart Disease](https://www.vat-trap.com/sugars-belly-fat-heart-disease)

---

## References

1. **Iadecola C.** The pathobiology of vascular dementia. *Neuron* 2013;80(4):844–866. doi:[10.1016/j.neuron.2013.10.008](https://doi.org/10.1016/j.neuron.2013.10.008)

2. **Gorelick PB, Scuteri A, Black SE, et al.** Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. *Stroke* 2011;42(9):2672–2713. doi:[10.1161/STR.0b013e3182299496](https://doi.org/10.1161/STR.0b013e3182299496)

3. **Schneider JA, Arvanitakis Z, Bang W, Bennett DA.** Mixed brain pathologies account for most dementia cases in community-dwelling older persons. *Neurology* 2007;69(24):2197–2204. doi:[10.1212/01.wnl.0000271090.28148.24](https://doi.org/10.1212/01.wnl.0000271090.28148.24)

4. **Livingston G, Huntley J, Sommerlad A, et al.** Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. *Lancet* 2020;396(10248):413–446. doi:[10.1016/S0140-6736(20)30367-6](https://doi.org/10.1016/S0140-6736(20)30367-6)

5. **de la Monte SM, Wands JR.** Alzheimer's disease is type 3 diabetes — evidence reviewed. *J Diabetes Sci Technol* 2008;2(6):1101–1113. doi:[10.1177/193229680800200619](https://doi.org/10.1177/193229680800200619)

6. **Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA.** Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. *Arch Neurol* 2004;61(5):661–666. doi:[10.1001/archneur.61.5.661](https://doi.org/10.1001/archneur.61.5.661)

7. **Biessels GJ, Despa F.** Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. *Nat Rev Endocrinol* 2018;14(10):591–604. doi:[10.1038/s41574-018-0048-7](https://doi.org/10.1038/s41574-018-0048-7)

8. **Pedersen BK.** Physical activity and muscle-brain crosstalk. *Nat Rev Endocrinol* 2019;15(7):383–392. doi:[10.1038/s41574-019-0174-x](https://doi.org/10.1038/s41574-019-0174-x)

9. **Erickson KI, Voss MW, Prakash RS, et al.** Exercise training increases size of hippocampus and improves memory. *Proc Natl Acad Sci USA* 2011;108(7):3017–3022. doi:[10.1073/pnas.1015950108](https://doi.org/10.1073/pnas.1015950108)

10. **Xie L, Kang H, Xu Q, et al.** Sleep drives metabolite clearance from the adult brain. *Science* 2013;342(6156):373–377. doi:[10.1126/science.1241224](https://doi.org/10.1126/science.1241224)

11. **SPRINT MIND Investigators.** Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. *JAMA* 2019;321(6):553–561. doi:[10.1001/jama.2018.21442](https://doi.org/10.1001/jama.2018.21442)

---

*This piece is part of the VAT Trap educational series and does not constitute individual medical advice.*